Revenio Group Oyj/€REG1V

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Revenio Group Oyj

Revenio Group Oyj, headquartered in Vantaa, Finland, specializes in ophthalmological devices and software solutions for diagnosing eye diseases such as glaucoma, macular degeneration, and diabetic retinopathy. Its product portfolio includes intraocular pressure measurement devices (tonometers), fundus imaging devices, perimeters, and clinical software under the iCare brand. The company operates globally, with subsidiaries in the United States, Italy, Australia, the United Kingdom, China, and the Netherlands. Revenio's strategic focus on eye care solutions aims to enhance the quality of clinical diagnostics through targeted product innovations and software solutions. (,)

Ticker

€REG1V

Primary listing

XHEL

Industry

Health Care Equipment & Supplies

Headquarters

Vantaa, Finland

Employees

246

ISIN

FI0009010912

REG1V Metrics

BasicAdvanced
€737M
38.78
€0.71
1.46
€0.40
1.44%

Bulls say / Bears say

Revenio Group Oyj's acquisition of Thirona Retina B.V. in August 2024 enhances its AI capabilities in ophthalmic diagnostics, potentially driving future growth. (tradingview.com)
The company reported a 7.2% increase in net sales for 2024, indicating strong demand for its products. (tradingview.com)
Revenio's efficient working capital management led to a significant improvement in operating cash flow, totaling EUR 23.9 million in 2024. (tradingview.com)
The company's operating profit decreased by 4.9% in 2024, suggesting potential challenges in maintaining profitability. (tradingview.com)
Revenio's P/E ratio of 38.36 is significantly higher than the industry average, indicating the stock may be overvalued. (stockanalysis.com)
The company's PEG ratio of 3.82 suggests that the stock's price may not be justified by its earnings growth, potentially deterring value-focused investors. (stockanalysis.com)
Data summarised monthly by Lightyear AI. Last updated on 30 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy €REG1V

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs